Antiviral activities of silymarin and derivatives

Ching Hsuan Liu; Alagie Jassey; Hsin Ya Hsu; Liang Tzung Lin

doi:10.3390/molecules24081552

Antiviral activities of silymarin and derivatives

Ching Hsuan Liu, Alagie Jassey, Hsin Ya Hsu, Liang Tzung Lin

Research output: Contribution to journal › Review article › peer-review

72 Citations (Scopus)

Abstract

Silymarin flavonolignans are well-known agents that typically possess antioxidative, anti-inflammatory, and hepatoprotective functions. Recent studies have also documented the antiviral activities of silymarin and its derivatives against several viruses, including the flaviviruses (hepatitis C virus and dengue virus), togaviruses (Chikungunya virus and Mayaro virus), influenza virus, human immunodeficiency virus, and hepatitis B virus. This review will describe some of the latest preclinical and clinical studies detailing the antiviral profiles of silymarin and its derivatives, and discuss their relevance for antiviral drug development.

Original language	English
Article number	1552
Journal	Molecules
Volume	24
Issue number	8
DOIs	https://doi.org/10.3390/molecules24081552
Publication status	Published - Apr 19 2019

Keywords

Antiviral
Drug development
Flavonolignans
Silymarin

ASJC Scopus subject areas

Analytical Chemistry
Chemistry (miscellaneous)
Molecular Medicine
Pharmaceutical Science
Drug Discovery
Physical and Theoretical Chemistry
Organic Chemistry

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3390/molecules24081552

Cite this

@article{54bd34ad8ad34d79a96f205f18205120,

title = "Antiviral activities of silymarin and derivatives",

abstract = "Silymarin flavonolignans are well-known agents that typically possess antioxidative, anti-inflammatory, and hepatoprotective functions. Recent studies have also documented the antiviral activities of silymarin and its derivatives against several viruses, including the flaviviruses (hepatitis C virus and dengue virus), togaviruses (Chikungunya virus and Mayaro virus), influenza virus, human immunodeficiency virus, and hepatitis B virus. This review will describe some of the latest preclinical and clinical studies detailing the antiviral profiles of silymarin and its derivatives, and discuss their relevance for antiviral drug development.",

keywords = "Antiviral, Drug development, Flavonolignans, Silymarin",

author = "Liu, {Ching Hsuan} and Alagie Jassey and Hsu, {Hsin Ya} and Lin, {Liang Tzung}",

note = "Publisher Copyright: {\textcopyright} 2019 by the authors.",

year = "2019",

month = apr,

day = "19",

doi = "10.3390/molecules24081552",

language = "English",

volume = "24",

journal = "Molecules",

issn = "1420-3049",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "8",

}

TY - JOUR

T1 - Antiviral activities of silymarin and derivatives

AU - Liu, Ching Hsuan

AU - Jassey, Alagie

AU - Hsu, Hsin Ya

AU - Lin, Liang Tzung

PY - 2019/4/19

Y1 - 2019/4/19

N2 - Silymarin flavonolignans are well-known agents that typically possess antioxidative, anti-inflammatory, and hepatoprotective functions. Recent studies have also documented the antiviral activities of silymarin and its derivatives against several viruses, including the flaviviruses (hepatitis C virus and dengue virus), togaviruses (Chikungunya virus and Mayaro virus), influenza virus, human immunodeficiency virus, and hepatitis B virus. This review will describe some of the latest preclinical and clinical studies detailing the antiviral profiles of silymarin and its derivatives, and discuss their relevance for antiviral drug development.

AB - Silymarin flavonolignans are well-known agents that typically possess antioxidative, anti-inflammatory, and hepatoprotective functions. Recent studies have also documented the antiviral activities of silymarin and its derivatives against several viruses, including the flaviviruses (hepatitis C virus and dengue virus), togaviruses (Chikungunya virus and Mayaro virus), influenza virus, human immunodeficiency virus, and hepatitis B virus. This review will describe some of the latest preclinical and clinical studies detailing the antiviral profiles of silymarin and its derivatives, and discuss their relevance for antiviral drug development.

KW - Antiviral

KW - Drug development

KW - Flavonolignans

KW - Silymarin

UR - http://www.scopus.com/inward/record.url?scp=85064871192&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064871192&partnerID=8YFLogxK

U2 - 10.3390/molecules24081552

DO - 10.3390/molecules24081552

M3 - Review article

C2 - 31010179

AN - SCOPUS:85064871192

SN - 1420-3049

VL - 24

JO - Molecules

JF - Molecules

IS - 8

M1 - 1552

ER -

Antiviral activities of silymarin and derivatives

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this